...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Free
Message: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS

Thanks for posting. Just be sure if you are the first to post a news release, please choose the "Press Release" option instead of the default "Message" so that it shows up in the Agoracom news feed. I just re-posted it this way....that's why I posted the news release again.

BearDownAZ

Share
New Message
Please login to post a reply